Excessive active pharmaceutical ingredients in substandard and falsified drugs should also raise concerns in low-income countries

J Glob Health. 2024 Jun 7:14:03029. doi: 10.7189/jogh.14.03029.

Authors

Elisa M Maffioli¹, Marie C Montás², Chimezie Anyakora^{3

4}

Affiliations

¹ University of Michigan, School of Public Health, Department of Health Management and Policy, Ann Arbor, Michigan, USA.
² Harvard T. H. Chan School of Public Health, Department of Global Health and Population, Boston, Massachusetts, USA.
³ Bloom Public Health, Abuja, Nigeria.
⁴ School of Science and Technology, Pan Atlantic University, Lagos, Nigeria.

No abstract available

Publication types

Review

MeSH terms

Bulk Drugs
Counterfeit Drugs*
Developing Countries*
Humans
Pharmaceutical Preparations / standards
Substandard Drugs / analysis

Substances

Counterfeit Drugs
Substandard Drugs
Pharmaceutical Preparations
Bulk Drugs